Segment Information

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Segment Information

(11)        Segment Information

The Company has five reportable segments which include: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, and Radiological Services. Information regarding the operations and assets of these reportable business segments is contained in the following table:

	Three months ended June 30,				Six months ended June 30,
Sale of Product	2020		2019		2020		2019
Radiochemical Products	$	1,113,053	$	774,107	$	1,868,274	$	1,237,339
Cobalt Products		224,666		213,239		530,286		589,328
Nuclear Medicine Standards		777,873		930,696		1,819,997		2,031,618
Radiological Services		43,967		217,797		116,288		805,406
Fluorine Products		—		—		160,500		—
Total Segments		2,159,559		2,135,839		4,495,345		4,663,691
Corporate revenue		—		—		—		—
Total Consolidated	$	2,159,559	$	2,135,839	$	4,495,345	$	4,663,691

	Three months ended June 30,					Six months ended June 30,
Depreciation and Amortization	2020			2019		2020		2019
Radiochemical Products	$	10,354		$	9,269	$	20,708	$	18,086
Cobalt Products		8,762			1,022		17,523		2,102
Nuclear Medicine Standards		15,989			15,673		31,978		31,292
Radiological Services		8,519			8,636		17,155		17,272
Fluorine Products		30,898			30,807		56,993		56,902
Total Segments		74,522			65,408		144,357		125,654
Corporate depreciation and amortization		(349	)		53		4,433		4,791
Total Consolidated	$	74,173		$	65,461	$	148,790	$	130,445

	Three months ended June 30,						Six months ended June 30,
Segment Income (Loss)	2020			2019			2020			2019
Radiochemical Products	$	380,728		$	252,946		$	386,347		$	349,002
Cobalt Products		75,874			122,252			199,670			315,122
Nuclear Medicine Standards		117,056			111,921			302,357			328,743
Radiological Services		(13,532	)		(901,234	)		(28,461	)		(589,955	)
Fluorine Products		(36,460	)		(39,927	)		86,410			(77,422	)
Total Segments		523,666			(454,042	)		946,323			325,490
Corporate loss		(294,338	)		(703,152	)		(1,139,489	)		(1,534,641	)
Net Income (Loss)	$	229,328		$	(1,157,194	)	$	(193,166	)	$	(1,209,151	)

	Three months ended June 30,				Six months ended June 30,
Expenditures for Segment Assets	2020		2019		2020		2019
Radiochemical Products	$	—	$	14,844	$	—	$	14,845
Cobalt Products		—		—		—		3,493
Nuclear Medicine Standards		—		4,950		—		4,950
Radiological Services		—		—		—		—
Fluorine Products		—		—		1,565		1,589
Total Segments		—		19,794		1,565		24,877
Corporate purchases		—		—		—		—
Total Consolidated	$	—	$	19,794	$	1,565	$	24,877

	June 30,		December 31,
Segment Assets	2020		2019
Radiochemical Products	$	748,827	$	511,381
Cobalt Products		1,331,242		3,369,828
Nuclear Medicine Standards		2,113,653		2,111,225
Radiological Services		84,012		106,374
Fluorine Products		5,422,380		5,477,808
Total Segments		9,700,114		11,576,616
Corporate assets		5,213,468		3,680,179
Total Consolidated	$	14,913,582	$	15,256,795